PATENT CLAIM ANALYSIS

Application Number: 16174293
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-05
Patent Classification: ["424", "062000"]

Abstract:
A method of preventing or treating cutaneous pigmentation disease in a subject in need thereof, includes: providing a pharmaceutical composition comprising SDF1, an inducer or activator of SDF1, as an active ingredient; and administering the pharmaceutical composition to the subject, wherein the cutaneous pigmentation is prevented or treated, and the cutaneous pigmentation disease is selected from the group consisting of melasma, freckles, lentigo, nevus, pigmentation by drugs, pigmentation after inflammation and hyperpigmentation incurred from dermatitis.

Claim (Index 2):
The method of  claim 1 , wherein the cutaneous pigmentation disease is selected from the group consisting of melasma, freckles, lentigo, nevus, pigmentation by drugs, pigmentation after inflammation and hyperpigmentation incurred from dermatitis.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 97.0
- Lexical Diversity: 1.66038
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14786475', '10997202', '14567033', '13851873', '13063016']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7635549580244575
- 35 USC 102 Novelty (BERT): 0.4885097760350451
- Combined Prediction Score: 0.7360504398255163
- Mean Citation Score: 209.06079800000003
- Max Citation Score: 226.2188
- Similarity Product: 170.2959727377415

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test